BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17507828)

  • 1. A novel drug therapy for recurrent laryngeal nerve injury using T-588.
    Mori Y; Shiotani A; Saito K; Araki K; Ikeda K; Nakagawa M; Watabe K; Ogawa K
    Laryngoscope; 2007 Jul; 117(7):1313-8. PubMed ID: 17507828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury.
    Araki K; Shiotani A; Watabe K; Saito K; Moro K; Ogawa K
    Gene Ther; 2006 Feb; 13(4):296-303. PubMed ID: 16251996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of a neuroprotective compound T-588 prevents motoneuron degeneration after facial nerve avulsion in adult rats.
    Ikeda K; Sakamoto T; Marubuchi S; Kawazoe Y; Terashima N; Iwasaki Y; Kinoshita M; Ono S; Nakagawa M; Watabe K
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Jun; 4(2):74-80. PubMed ID: 14506937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus.
    Moro K; Shiotani A; Watabe K; Takeda Y; Saito K; Mori Y; Ogawa K
    Brain Res; 2006 Mar; 1076(1):1-8. PubMed ID: 16473328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations of recurrent laryngeal nerve injury and recovery using a rat model.
    Tessema B; Roark RM; Pitman MJ; Weissbrod P; Sharma S; Schaefer SD
    Laryngoscope; 2009 Aug; 119(8):1644-51. PubMed ID: 19504559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injury.
    Bergerot A; Shortland PJ; Anand P; Hunt SP; Carlstedt T
    Exp Neurol; 2004 Jun; 187(2):359-66. PubMed ID: 15144862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring vocal fold movement after transection and immediate suturing of the recurrent laryngeal nerve with local application of basic fibroblast growth factor: an experimental study in the rat.
    Motoyoshi K; Hyodo M; Yamagata T; Gyo K
    Laryngoscope; 2004 Jul; 114(7):1247-52. PubMed ID: 15235355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal survival and glial reactions after recurrent laryngeal nerve resection in the rat.
    Hydman J; Svensson M; Kuylenstierna R; Ohlsson M; Mattsson P
    Laryngoscope; 2005 Apr; 115(4):619-24. PubMed ID: 15805870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of human insulin-like growth factor-1 gene transfer in reinnervating laryngeal muscle.
    Nakagawa H; Shiotani A; O'Malley BW; Coleman ME; Flint PW
    Laryngoscope; 2004 Apr; 114(4):726-32. PubMed ID: 15064631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury.
    Sharma HS
    Ann N Y Acad Sci; 2007 Dec; 1122():95-111. PubMed ID: 18077567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterisation of an experimental recurrent laryngeal nerve injury model for the study of viral gene therapy.
    Fung K; Hogikyan ND; Heavner SB; Ekbom D; Feldman EL
    J Laryngol Otol; 2008 May; 122(5):500-5. PubMed ID: 17592655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral reinnervation by the superior laryngeal nerve after recurrent laryngeal nerve injury.
    Hydman J; Mattsson P
    Muscle Nerve; 2008 Oct; 38(4):1280-9. PubMed ID: 18816603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for laryngeal paralysis.
    Shiotani A; Saito K; Araki K; Moro K; Watabe K
    Ann Otol Rhinol Laryngol; 2007 Feb; 116(2):115-22. PubMed ID: 17388235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of autologous muscle stem cell survival in the denervated hemilarynx.
    Halum SL; Hiatt KK; Naidu M; Sufyan AS; Clapp DW
    Laryngoscope; 2008 Jul; 118(7):1308-12. PubMed ID: 18401272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of fibroblast growth factor-2 in the nucleus ambiguus following recurrent laryngeal nerve injury in the rat.
    Sanuki T; Yumoto E; Komori M; Hyodo M
    Laryngoscope; 2000 Dec; 110(12):2128-34. PubMed ID: 11129035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of glial-derived neurotrophic factor in rat laryngeal muscles during reinnervation.
    Hernandez-Morato I; Isseroff TF; Sharma S; Pitman MJ
    Laryngoscope; 2014 Dec; 124(12):2750-6. PubMed ID: 25220603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapy.
    Rubin AD; Hogikyan ND; Oh A; Feldman EL
    Laryngoscope; 2012 Feb; 122(2):349-55. PubMed ID: 22241608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous mesenchymal stem cell therapy after recurrent laryngeal nerve injury: a preliminary study.
    Lerner MZ; Matsushita T; Lankford KL; Radtke C; Kocsis JD; Young NO
    Laryngoscope; 2014 Nov; 124(11):2555-60. PubMed ID: 25043703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of an adenoviral vector to the crushed recurrent laryngeal nerve.
    Rubin A; Mobley B; Hogikyan N; Bell K; Sullivan K; Boulis N; Feldman E
    Laryngoscope; 2003 Jun; 113(6):985-9. PubMed ID: 12782809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reorganization of laryngeal motoneurons after crush injury in the recurrent laryngeal nerve of the rat.
    Hernández-Morato I; Valderrama-Canales FJ; Berdugo G; Arias G; McHanwell S; Sañudo J; Vázquez T; Pascual-Font A
    J Anat; 2013 Apr; 222(4):451-61. PubMed ID: 23444899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.